Effect of fasting hyperglycemia and insulin resistance on bone turnover markers in children aged 9-11 years

J Diabetes Complications. 2021 Oct;35(10):108000. doi: 10.1016/j.jdiacomp.2021.108000. Epub 2021 Jul 30.

Abstract

Aim: Impaired regulation of glucose metabolism in childhood adversely affects bone health. We assessed the effect of fasting hyperglycemia and insulin resistance on bone turnover markers in prepubertal children with normal glycemia (<100 mg/dL) and fasting hyperglycemia (100-125 mg/dL).

Methods: Glucose, hemoglobin A1c, IGF-I (insulin-like growth factor I), iP1NP (N-terminal propeptide of type I procollagen), CTX-1 (C-terminal telopeptide of type I collagen) and insulin were measured. Bone turnover index (BTI) and HOMA-IR (homeostasis model assessment) were calculated.

Results: Bone resorption marker (CTX) levels were decreased by 26.5% in boys with hyperglycemia, though only 7% in girls. Hyperglycemia had no effect on the bone formation marker iP1NP. IGF-1, the best predictor of bone marker variance accounted for 25% of iP1NP and 5% of CTX variance. Girls presented significantly higher BTI indicating the predominance of bone formation over resorption. Insulin resistance significantly decreased CTX. In girls, HOMA-IR and IGF-1 predicted 15% of CTX variance.

Conslusions: Fasting hyperglycemia and insulin resistance in children impact bone turnover suppressing bone resorption. Hyperglycemia decreased resorption, particularly in boys, while suppression of resorption by insulin resistance was more pronounced in girls. We suggest that the progression of disturbances accompanying prediabetes, may interfere with bone modelling and be deleterious to bone quality in later life.

Keywords: Bone turnover markers; Hyperglycemia; Insulin resistance; Osteoblasts; Osteoclasts.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / blood
  • Bone Remodeling*
  • Bone Resorption*
  • Child
  • Fasting
  • Female
  • Humans
  • Hyperglycemia*
  • Insulin Resistance*
  • Insulin-Like Growth Factor I / analysis
  • Male

Substances

  • Biomarkers
  • Insulin-Like Growth Factor I